Wong Kin Sang – Country Manager, Lundbeck Malaysia
Wong Kin Sang, country manager of Lundbeck Malaysia, walks us through the mental health issues’ perception in Malaysia and the important work Lundbeck has done to bring more awareness to…
Healwell Pharmaceuticals was founded by Prof. Dato’ Dr. Hassan Yaacob, when he was still a Researcher at University Malaya. After many years of intensive R&D into the benefits of gamat, he turned entrepreneur and commercialised gamat and gamat- based products. He is a PhD holder in Clinical Pharmacology from Royal College of Surgeons of England, London. He is also an Executive Chairman/CEO of the Company.
Healwell Pharmaceuticals was established in 1996 to manufacture and market gamat and its by-products on a commercial basis. Gamat is a type of sea cucumber found in abundance in the waters off the shores of Langkawi, Kedah.
After more than 10 years of R&D, Healwell Pharmaceuticals was able to market its products under the brand name of HEALIN in Malaysia.
Over the years, the company has placed itself as a leading Bumiputra Company that markets high quality, trusted, ethical and halal natural-based products. Through extensive R&D, the products were proven to enhance the body’s resistance towards various diseases besides having a cell growth factor.
Healwell Pharmaceuticals has gained a reputation as a respected company, known for the introduction of new concepts of health and skin care focusing specially on sophistication, simple yet effective.
Address:
NO.1, JALAN KARTUNIS U1/47,
SEK U1, TEMASYA INDUSTRIAL PARK,
40150 SHAH ALAM
SELANGOR.
Tel : 03-5569 5580
Fax : 03-5569 5581
EMAIL : info@healwell.com.my
Wong Kin Sang, country manager of Lundbeck Malaysia, walks us through the mental health issues’ perception in Malaysia and the important work Lundbeck has done to bring more awareness to…
Dr Hyzan Mohd Yusof, CEO at OSA Technology, tells the story of how he founded the company to address Malaysia’s unmet needs in medical devices as well as his vision…
How Malaysia is setting itself up to provide biosimilars across the Islamic world as well as Asia. Inno Bio Ventures, a Malaysian state-owned company originally set up to create…
Dr Ramli Zainal, the director at National Pharmaceutical Regulatory Agency (NPRA), expresses the continuous work of NPRA to build a strong regulatory ecosystem in Malaysia and the important role that…
Tan Sri Rahman Mamat, chairman of Inno Bio Ventures, provides his vision for biosimilars’ potential in Malaysia, and the progress the company has made in laying the foundations to make…
George Kazzi, general manager of Baxter Malaysia, highlights the main areas of development for his affiliate, including the introduction of more renal dialysis innovation as well as increasing awareness and…
Dr Dhesi Baha Raja, consultant in digital technologies at the Malaysian Ministry of Health, introduces the government’s plan to enter digital health through electronic medical records (EMR) and shares his…
Kshitij Panse, director of Servier Malaysia discusses the company’s planned move into oncology, as well as their strategies to provide an all-round improved patient experience, through education, screening, and e-health.…
Datuk Dr Noor Hisham Abdullah, director general of health at the Ministry of Health of Malaysia unveils the government’s plan to bring healthcare back to the community, and create a…
Dr. Azrul Mohd Khalib, chief executive at the Galen Centre for Health and Social Policy, gives an insight on the current important issues the Malaysian healthcare ecosystem is facing and…
Malaysia’s multi-ethnic population, disease burden, medical infrastructure and research speed, combined with its population’s proficiency in English, make the Southeast Asian nation a potentially excellent regional clinical trials destination. …
Shahnas Oli Mohamed, the managing director of Natural Wellness Holdings Sdn Bhd, expresses the important work that Natural Wellness has done to provide natural healthcare products to Malaysian patients, including…
See our Cookie Privacy Policy Here